PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F0DQ0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $234,535
Award facts
- Contract value 100% obligated
- $234,534.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $234,534.60 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare systems, supplying an extensive portfolio of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
This delivery order supports the Defense Logistics Agency's mission to provide comprehensive pharmaceutical and medical supply support to military treatment facilities and federal healthcare programs worldwide. AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 2031, demonstrating the company's substantial role in the federal pharmaceutical supply chain. The competitively awarded contract reflects AmerisourceBergen's demonstrated capability to efficiently fulfill government requirements for essential medical commodities and supports the broader Defense Logistics Agency strategy of utilizing prime vendor relationships to ensure reliable pharmaceutical distribution across military healthcare networks.
Quick answers
Who was awarded contract SPE2D826F0DQ0?
SPE2D826F0DQ0 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 6, 2026.
How much is contract SPE2D826F0DQ0 worth?
The government has obligated $234,535 on SPE2D826F0DQ0.
Is contract SPE2D826F0DQ0 an order under another contract?
Yes. SPE2D826F0DQ0 is a delivery order under SPE2DX22D0039, an indefinite delivery contract.
Was contract SPE2D826F0DQ0 competed?
The extent of competition for SPE2D826F0DQ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award